Work

78P Dynamic immune modulation by dendritic cell vaccination and IFN-α in advanced melanoma: Final insights from the ABSIDE phase II trial

Year: 2025

Type: article

Abstract: Advanced melanoma remains a clinical challenge despite therapeutic progress. The ABSIDE trial investigated an autologous dendritic cell vaccine (DCvax) alone or in combination with radiotherapy (RT) and/or short-course IFN-α to evaluate safety, clinical activity, and immune modulation.

Source: Immuno-Oncology Technology

DOI: 10.1016/j.iotech.2025.101163

Author: J. Bulgarelli

Institution: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,340